2-Amino-9-((2R,4R,5R)-4-Hydroxy-5-(Hydroxymethyl) Tetrahydrofuran-2-Yl)-1,4,5,9-Tetrahydro-6H-Purine-6-Thione

2 trials 2 recruiting

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

2 Recruiting

0 Completed trials

1 Sponsors

5 Countries

Phase III

Phase II

Phase III: 1 Phase II: 1

Indications tested

Non-small cell lung cancer 2 Non-small cell lung cancer stage IV 2 Non-small cell lung cancer stage III 2

Sponsors using this IMP

Maia Biotechnology Inc. 2

All trials

2 total

A Multicenter, Open-Label, Dose-Finding, Phase 2 Study Evaluating THIO Sequenced with Cemiplimab (LIBTAYO®) in Subjects with Advanced Non-Sm… Recruiting

2023-504595-26-00 Phase II 4 countries Maia Biotechnology Inc.
A Multicenter, Open-label, Randomized Phase 3 Study Evaluating THIO Sequenced with Cemiplimab (LIBTAYO®) vs Investigator Choice of Single-ag… Recruiting

2024-520164-33-00 Phase III 4 countries Maia Biotechnology Inc.

Showing 1–2 of 2 trials

← All drugs A–Z